Literature DB >> 25044399

Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats.

Amany M El-Garhy1, Ola M Abd El-Raouf, Bahia M El-Sayeh, Hala M Fawzy, Dalaal M Abdallah.   

Abstract

Ellagic acid (EA) renoprotective effect against cisplatin (CIS)-induced nephrotoxicity remains elusive. Therefore, male Sprague-Dawley rats received CIS alone or EA (10 and 30 mg/kg, p.o.) for 5 days before and after CIS injection. CIS increased serum levels of blood urea nitrogen, creatinine, γ-glutamyl transferase, and reduced those of albumin and total protein. It also raised serum endothelin-1, as well as serum and renal nitric oxide, tumor necrosis factor-α, and monocyte chemoattractant protein-1. CIS enhanced the renal caspase-3, hemeoxygenase (HO)-1, nuclear factor-κB, and inducible nitric oxide. EA hampered CIS-induced nephrotoxicity manifested by an enhancement of the glomerular filtration rate which was associated by the reduction of inflammatory mediators and the apoptotic marker in the serum and/or kidney. The present study discloses that EA suppresses HO-1 and, its renoprotection is also linked to its anti-inflammatory and antiapoptotic properties, as well as the reduction of nitric oxide and endothelin-1.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Apoptosis; Cisplatin; Ellagic Acid; Inflammation; Nephrotoxicity

Mesh:

Substances:

Year:  2014        PMID: 25044399     DOI: 10.1002/jbt.21587

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  9 in total

1.  Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.

Authors:  Iman O Sherif; Laila A Al-Mutabagani; Anwar M Alnakhli; Mohamed A Sobh; Hoda E Mohammed
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-29

Review 2.  The Effects of Ellagic Acid upon Brain Cells: A Mechanistic View and Future Directions.

Authors:  Marcos Roberto de Oliveira
Journal:  Neurochem Res       Date:  2016-02-04       Impact factor: 3.996

3.  Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.

Authors:  Blanca Humanes; Sonia Camaño; Jose Manuel Lara; Venkatta Sabbisetti; María Ángeles González-Nicolás; Joseph V Bonventre; Alberto Tejedor; Alberto Lázaro
Journal:  Nephrol Dial Transplant       Date:  2017-10-01       Impact factor: 5.992

Review 4.  Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity.

Authors:  Shreesh Ojha; Balaji Venkataraman; Amani Kurdi; Eglal Mahgoub; Bassem Sadek; Mohanraj Rajesh
Journal:  Oxid Med Cell Longev       Date:  2016-09-27       Impact factor: 6.543

5.  Effects of ellagic acid pretreatment on renal functions disturbances induced by global cerebral ischemic-reperfusion in rat.

Authors:  Khojasteh Hoseiny Nejad; Mohammad Kazem Gharib-Naseri; Alireza Sarkaki; Mahin Dianat; Mohammad Badavi; Yaghoub Farbood
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

6.  Double-Negative T Cells Attenuate Cisplatin-Induced Acute Kidney Injury via Upregulating IL-10/AT2R Axis.

Authors:  Jing Gong; Jingjing Wu; Mingshun Zhang; Weihua Gan
Journal:  Comput Math Methods Med       Date:  2022-07-30       Impact factor: 2.809

7.  Synaptic plasticity and cognitive impairment consequences to acute kidney injury: Protective role of ellagic acid.

Authors:  Alireza Sarkaki; Sarkaki Hoseinynejad; Maryam Khombi Shooshtari; Mohammad Rashno
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

8.  Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity.

Authors:  Ya-Hong Liu; Kui Li; Hong-Qi Tian
Journal:  Oxid Med Cell Longev       Date:  2020-04-18       Impact factor: 6.543

9.  Inhibition of Histone H3K27 Acetylation Orchestrates Interleukin-9-Mediated and Plays an Anti-Inflammatory Role in Cisplatin-Induced Acute Kidney Injury.

Authors:  Wenjuan Jiang; Xinrong Yuan; Hong Zhu; Changsheng He; Caiqiong Ge; Qing Tang; Chuanting Xu; Bingfeng Hu; Cheng Huang; Taotao Ma
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.